EP4321157
NÝ NOTKUN Á SAMSETNINGU ANGÍÓTENSÍN VIÐTAKABLOKKARA (ARB) MEÐ HLUTLAUSUM INNRÆNUM PEPTÍÐASIBLOKKARA (NEPI)
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
26.8.2014EP published:
23.10.2024EP application number:
23202190.7
EP translation filed:
3.2.2025Grant published:
15.3.2025EPO information:
European Patent Register
Max expiry date:
25.8.2034Expiry date:
25.8.2026Next due date:
31.8.2026
Title in English:
NEW USE OF A COMBINATION OF AN ANGIOTENSIN RECEPTOR BLOCKER (ARB) WITH A NEUTRAL ENDOPEPTIDASE INHIBITOR (NEPI)Language of the patent:
English
Timeline
Today
26.8.2014EP application
23.10.2024EP Publication
3.2.2025Translation submitted
15.3.2025Registration published
25.8.2026Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
SHI, Victor ChengweiAddress:
New Jersey, US
Name:
LEFKOWITZ, MartinAddress:
New Jersey, US
Name:
RIZKALA, Adel RemondAddress:
New Jersey, US
Agent
Name:
Zacco Denmark A/SAddress:
Arne Jacobsens Allé 15, DK
Priority
Number:
PCT/US2013/056680Date:
26.8.2013Country:
WO
Number:
201461972933 PDate:
31.3.2014Country:
US
Classification
Categories:
A61K 31/194, A61K 31/197, A61K 31/216, A61K 31/41, A61K 31/221, A61K 45/06, A61K 31/401, A61K 31/225, A61P 9/12, A61P 9/10
Annual fees
Number
Paid
Expires
Payer
Number: 12
Paid: 11.8.2025
Expires: 25.8.2026
Payer: Árnason Faktor ehf.